Published in AIDS Weekly, September 13th, 1999
In this study, C. Connolly and colleagues from Durban, South Africa's Centre for Epidemiological Research examined post-treatment relapse and mortality rates among HIV infected and uninfected patients with tuberculosis treated with a twice-weekly drug regimen under direct observation (DOT) in Hlabisa, South Africa.
A group of 403 patients with tuberculosis (53 percent HIV infected) were cured following...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.